Concepedia

Study protocol of a randomised controlled trial of prostate radiotherapy in high-risk and node-positive disease comparing moderate and extreme hypofractionation (PRIME TRIAL)

Vedang Murthy, Indranil Mallick, Abhilash Gavarraju, Shwetabh Sinha, Rahul Krishnatry, Tejshri Telkhade, Moses Arunsingh, Sadhna Kannan, Gagan Prakash, Mahendra Pal,

BMJ Open · 2020 · 27 citations · 16 references

DOIFull text

Open access

Abstract

Registered with CTRI/2018/05/014054 (http://ctri.nic.in) on 24 May 2018.

References

16

Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer

Matthew R. Cooperberg, Jeanette M. Broering, Peter R. Carroll · Journal of Clinical Oncology · 2010 · 1K citations · Full text

, , +22

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

Anders Widmark, Adalsteinn Gunnlaugsson, L. Beckman et al. · The Lancet · 2019 · 840 citations

, , +8

Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial

Douglas Brand, Alison Tree, Peter Ostler et al. · The Lancet Oncology · 2019 · 519 citations · Full text

Stereotactic body radiotherapy for localized prostate cancer: Pooled analysis from a multi-institutional consortium of prospective phase II trials

Christopher R. King, Debra Freeman, Irving Kaplan et al. · Radiotherapy and Oncology · 2013 · 454 citations · Full text

Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: preliminary safety results from the CHHiP randomised controlled trial

David P. Dearnaley, Isabel Syndikus, G. Sumo et al. · The Lancet Oncology · 2011 · 304 citations · Full text